Hughes Owen, CEO of XOMA Royalty Corp ($XOMA), made one open market sale of common shares in the last 365 days, totaling $650,667. His most recent sale occurred on May 20, 2025. Among 11,678 insiders with sales over the period, his activity ranks 5,922nd by value, below the average of $8.6 million across 6.37 transactions per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | A | Common Stock | 82428 | $0.00 | 180,991.0000 | 18,141,000 | 83.63% | 0.45% |
| March 16, 2026 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | A | Performance Stock Units | 126813 | $0.00 | 126,813.0000 | 18,141,000 | 9999.99% | 0.70% |
| Dec. 4, 2025 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | P | Depositary Shares - 8.375% B Cumulative Stock | 100000 | $25.05 | 102,000.0000 | 18,141,000 | 5000.00% | 0.55% |
| Sept. 19, 2025 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | M | Performance Stock Units | 35567 | $0.00 | 132,714.0000 | 17,761,000 | 21.14% | 0.20% |
| Sept. 19, 2025 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | M | Common Stock | 35567 | $0.00 | 98,563.0000 | 17,761,000 | 56.46% | 0.20% |
| June 18, 2025 | C4 Therapeutics, Inc. | $CCCC | Hughes Owen | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| May 20, 2025 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | S | Common Stock | 25637 | $25.38 | 62,996.0000 | 17,781,000 | 28.92% | 0.14% |
| May 19, 2025 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | M | Common Stock | 53359 | $0.00 | 88,633.0000 | 17,781,000 | 151.27% | 0.30% |
| May 19, 2025 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | M | Performance Stock Units | 53359 | $0.00 | 168,281.0000 | 17,781,000 | 24.07% | 0.30% |
| Nov. 11, 2024 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | M | Common Stock | 53360 | $0.00 | 56,860.0000 | 11,712,000 | 1524.57% | 0.46% |
| Nov. 13, 2024 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | S | Common Stock | 21881 | $29.95 | 34,979.0000 | 11,712,000 | 38.48% | 0.19% |
| Nov. 11, 2024 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | M | Performance Stock Units | 53360 | $0.00 | 221,640.0000 | 11,712,000 | 19.40% | 0.46% |
| June 20, 2024 | C4 Therapeutics, Inc. | $CCCC | Hughes Owen | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2024 | ImageneBio, Inc. | $IMA | Hughes Owen | Not found | A | Stock Option (Right to Buy) | 17520 | $0.00 | 17,520.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2024 | XOMA Royalty Corp | $XOMA | Hughes Owen | Chief Executive Officer | A | Performance Stock Units | 275000 | $0.00 | 275,000.0000 | 11,471,000 | 9999.99% | 2.40% |